BioCryst Pharmaceuticals, Inc.
METHODS OF TREATING HEMATOLOGIC CANCERS
Last updated:
Abstract:
The present application relates to treatment of hematologic cancers, which treatments can include, e.g., administration of a purine nucleoside phosphorylase (PNP) inhibitor, an alkylating agent and/or an anti-CD20 agent, and related compositions and kits.
Status:
Application
Type:
Utility
Filling date:
1 May 2019
Issue date:
22 Aug 2019